CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,245 enrolled
Drug / intervention
Private sector component + modified BCCother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04335877
NCT04335877N/ACompleted
CompareCT.gov

Effectiveness-Implementation Research to Assess the Effect of Prompting the Supply of Zinc/LO-ORS Co-packs Through the Private Sector Coupled With Behavior Change Intervention on the Treatment of Uncomplicated Childhood Diarrhoea in Kenya

Nutrition International·interventional·Posted Apr 6, 2020·Updated Apr 6, 2023

In Brief

A clinical study evaluating Private sector component + modified BCC for Diarrhea, Infantile. Completed, enrolled 1,245 participants across 1 site.

Detailed Summary

This study assesses whether prompting the supply of zinc and LO-ORS co-packs in the private sector coupled with behavior change communication (BCC) has an effect on the treatment of uncomplicated childhood diarrhea. In addition the study will evaluate the acceptability, adoption, feasibility and coverage of the intervention model. One group of children and caregivers will receive the current standard of care and will be exposed to standard BCC and the second group will be exposed to the private sector component and to a modified BCC.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhea, Infantile
CountriesKenya
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 6, 2020
Enrollment StartMar 1, 2021
Primary CompletionApr 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.2 years ago

Interventions

Private sector component + modified BCCother

Intervention group will be exposed to the private sector component + modified BCC and will receive current standard care